The German Consortium for Translational Cancer Research DKTK

New, promising results from cancer research should be translated into clinical development and application as quickly as possible. To support this goal, the German Consortium for Translational Cancer Research, or DKTK for short, was founded in 2012 as one of the German Centers for Health Research (DZG). With the German Cancer Research Center (DKFZ) as its core center, more than 20 academic research institutions and university hospitals cooperate in translational centers at eight partner sites.

DKTK is well-represented across Munich, and the Department for Translational Oncology (MU08) is located at the LMU Klinikum in Großhadern. The department is recently refurbished and boasts excellent facilities.